11/19/2024
5:40 PM | Nant Capital, LLC (Reporting)
Panbela Therapeutics (Issuer)
SOON-SHIONG PATRICK (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
3:59 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/18/2024
4:00 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/18/2024
4:01 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/18/2024
4:02 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/18/2024
4:03 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/18/2024
4:04 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
|
11/18/2024
4:05 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/18/2024
3:16 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
5:00 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/15/2024
5:15 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/15/2024
5:03 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/15/2024
5:06 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/15/2024
5:09 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/15/2024
5:12 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/15/2024
5:12 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
6:40 PM | Nant Capital, LLC (Filed by)
Panbela Therapeutics (Subject)
| Form SC 13D | |
10/29/2024
6:38 PM | Nant Capital, LLC (Reporting)
Panbela Therapeutics (Issuer)
SOON-SHIONG PATRICK (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/29/2024
8:24 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
8:24 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
8:25 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
8:25 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
8:26 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
8:26 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
8:27 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/28/2024
4:16 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
3:26 PM | Horvath Susan (Reporting)
Panbela Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
3:34 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2024
4:25 PM | Panbela Therapeutics (Filer)
| Form S-1/A | |
08/13/2024
7:39 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
7:40 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
7:42 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
7:43 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
7:45 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
7:46 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
7:47 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
4:08 PM | Panbela Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/30/2024
4:30 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
07/30/2024
3:59 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2024
3:46 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2024
6:00 AM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Buffett Dumps $982 Million in BofA Stock—What Does He Know? (Ad) Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention. Get your FREE, no-obligation Wealth Protection Guide now |
05/15/2024
7:21 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
05/15/2024
7:22 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
05/15/2024
7:24 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
05/15/2024
7:27 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
05/15/2024
7:29 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
05/15/2024
3:16 PM | Panbela Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024
3:35 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2024
8:09 AM | Nasdaq Stock Market LLC (Filed by)
Panbela Therapeutics (Subject)
| Form 25-NSE | |
04/22/2024
7:02 AM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/18/2024
3:31 PM | Panbela Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
04/17/2024
7:36 AM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2024
11:15 PM | Panbela Therapeutics (Filer)
| Form EFFECT | |
04/04/2024
3:17 PM | Panbela Therapeutics (Filer)
| Form DEF 14A | |
04/02/2024
11:15 PM | Panbela Therapeutics (Filer)
| Form EFFECT | |
03/29/2024
4:08 PM | Panbela Therapeutics (Filer)
| Form POS AM | |
03/29/2024
4:24 PM | Panbela Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
03/26/2024
3:15 PM | Panbela Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2024
3:12 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2024
5:01 AM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
7:05 AM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
7:10 PM | Lind Global Fund II LP (Filed by)
Panbela Therapeutics (Subject)
| Form SC 13G/A | |
02/13/2024
4:24 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/01/2024
6:15 AM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/30/2024
4:28 PM | Panbela Therapeutics (Filer)
| Form 424B4 | |
01/29/2024
5:21 AM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/28/2024
11:15 PM | Panbela Therapeutics (Filer)
| Form EFFECT | |
01/25/2024
11:22 AM | Panbela Therapeutics (Filer)
| Form S-1/A | |
01/25/2024
7:54 AM | Panbela Therapeutics (Filer)
| Form S-1/A | |
01/22/2024
5:08 AM | Panbela Therapeutics (Filer)
| Form S-1/A | |
01/19/2024
4:20 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
3:34 PM | Panbela Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/05/2024
11:48 AM | Panbela Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
12/21/2023
8:25 AM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/21/2023
8:25 AM | Panbela Therapeutics (Filer)
| Form DEFA14A | |
12/20/2023
11:15 PM | Panbela Therapeutics (Filer)
| Form EFFECT | |
12/21/2023
5:00 AM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/24/2023
3:30 PM | Panbela Therapeutics (Filer)
| Form DEF 14A | |
